For help on how to get the results you want, see our search tips.
29 results
Categories
Human Remove Human filter
Medicine
Referrals Remove Referrals filter
Referral type
Article 31 referrals Remove Article 31 referrals filter
Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter
Referral decision making model
PRAC-CMDh Remove PRAC-CMDh filter
Referral authorisation model
Nationally authorised product(s) Remove Nationally authorised product(s) filter
-
List item
Referral: Terlipressin-containing medicinal products indicated in the treatment of hepatorenal syndrome
terlipressin, Article 31 referrals
Status: CMDh final position, opinion/position date: 10/11/2022, Last updated: 22/11/2022 -
List item
Referral: Substances related to nicotinic acid
acipimox, associated names: Olbetam, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/12/2013, EC decision date: 20/02/2014, Last updated: 13/03/2014 -
List item
Referral: Hydroxyprogesterone-containing medicinal products
hydroxyprogesterone, associated names: Lentogest, Progesterone Retard Pharlon, Proluton Depot, Article 31 referrals
Status: Under evaluation, Last updated: 29/09/2023 -
List item
Referral: Topiramate (updated)
topiramate, Article 31 referrals
Status: CMDh final position, opinion/position date: 10/11/2023, Last updated: 23/11/2023